top of page

About Prosoma

Prosoma is a privately held pharmaceutical and nutraceutical company headquartered in Clearwater, FL. Prosoma is focused on the development, production, marketing and distribution of a wide range of pharmaceutical and medical food products.


Physicians choose Prosoma for their patients' treatments because of our commitment to providing the world's highest quality, leading-edge medical foods and nutraceuticals, delivered with a commitment to the highest cGMP safety and quality standards.


Prosoma continues to invest significantly in research, technology development, and commercial production, as well as the introduction of innovative nutritional ingredient products.​

Strong science and research is at the core of Prosoma. Responsible for this is the company's Scientific Director, Richard F. Walker, Ph.D, R.Ph. Dr. Walker received a BS in pharmacy from Rutgers University, a MS in biochemistry from New Mexico State University and a PhD in a physiology from Rutgers University.  He completed an internship in neuroanatomy at Emory University College of Medicine, and postdoctoral fellowships in neuroendocrinology and neuropharmacology at Duke University College of Medicine (Center for the Study of Aging and Human Development) and the University of California, Berkeley, respectively.  Dr. Walker held tenured faculty positions at Clemson University (Department of Zoology) and at the University of Kentucky College of Medicine (Department of Anatomy and Molecular Biology/Sanders-Brown Research Center on Aging).  He left academia for a brief hiatus in the pharmaceutical industry serving as Director of Toxicology at SmithKline Beecham Pharmaceutical Corp.  At the same time he was also research professor in the Department of Pharmacology at the Medical College of Pennsylvania and later at the University of South Florida (USF).  In addition to his research duties at USF, Dr. Walker served as Director for Research Compliance and also Director of USF CARES (Clinical Alliance for Research, Education and Service).  He has been the recipient of many federal (NSF, NIH, DOD), state and local research grants and has published extensively in his field of interest which is primarily directed towards understanding the cause of senescence and treating functional deficits associated with organismal aging.  Dr. Walker is currently Editor-in-Chief of Clinical Interventions in Aging, a source of evidence-based information for practitioners of age-management medicine published by Dove Medical Press ( , Auckland and London) and author of the book, “Why We Age: Insight into the cause of growing old”  

bottom of page